Meperidine

DEMEROL

Opioid Agonist

NADAC/unit $0.1552

Active Shortage Tier 1: 2.1% PA Req: 3.6% 4 Manufacturers 13 ANDAs

Meperidine relieves moderate to severe pain by acting on opioid receptors in the brain.

vs. brand DEMEROL: Generic saves up to 98% per unit

Covered Lives

Active Shortages

2025-05-30 Next Delivery: April 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company

2025-05-30 Next Delivery and Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company

2025-05-30 Next Delivery and Estimated Recovery: December 2027, Hospira, Inc., a Pfizer Company

2025-05-30 Shortage reported, Hospira, Inc., a Pfizer Company

Generic Manufacturers

EPIC PHARMA LLCGENUS LIFESCIENCES INCHIKMA PHARMACEUTICALS USA INCHOSPIRA INCWEST-WARD PHARMACEUTICALS INTERNATIONAL LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Meperidine drfinder.aiFind doctors who prescribe Meperidine hipreplacement.aiLearn about post-surgical pain management rxbenefits.aiEmployer cost impact analysis

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.